alexa MRSA [Methicillin Resistant Staphylococcus aureus] | China | PDF | PPT| Case Reports | Symptoms | Treatment

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Recommended Journals

Relevant Topics

MRSA [Methicillin Resistant Staphylococcus Aureus]

  • Share this page
  • Facebook
  • Twitter
  • LinkedIn
  • Google+
  • Pinterest
  • Blogger
  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Pathophysiology: Methicillin-resistant Staphylococcus aureus (MRSA) is a bacterium responsible for several difficult-to-treat infections in humans. Healthy individuals may carry MRSA asymptomatically for periods ranging from a few weeks to many years. Patients with compromised immune systems are at a significantly greater risk of symptomatic secondary infection. Initial treatment of the infection is often based upon quick detecting and identifying MRSA strains.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Statistics: There was no geographical clustering of the 82 confirmed cases among the 4 districts in Hong Kong (Hong Kong Island 27%, Kowloon 28%, New Territories East 20% and New Territories West 26%). The average lag time from the date of symptoms onset to date of notification was 21 days.The 82 cases comprised 45 males and 37 females. Their ages ranged from 12 days to 93 years (median 32 years). 80% were adults aged between 20 and 59 years. About 15% (12 cases) were children under 18 years of age.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Treatment: Healthcare providers can treat many S. aureus skin infections by draining the abscess or boil and may not need to use antibiotics. Draining of skin boils or abscesses should only be done by a healthcare provider. For mild to moderate skin infections, incision and drainage by a healthcare provider is the first-line treatment.

  • MRSA [Methicillin Resistant Staphylococcus aureus]

    Major Research: Some in vitro studies with honey have identified components in honey that kill MRSA. Ocean-dwelling living sponges produce compounds that may make MRSA more susceptible to antibiotics. Some semi-toxic fungi/mushrooms excrete broad spectrum antibiotics, not all of which have been fully identified; some have been shown to inhibit the growth of Staphylococcus aureus.

Expert PPTs

Speaker PPTs

 

High Impact List of Articles

Conference Proceedings

adwords